Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New PDE3/4 inhibitors undergo extensive preclinical evaluation at Vernalis

Nov. 8, 2000

Roche's new antidiabetic agents act as glucokinase activators

Nov. 8, 2000

Takara Shuzo identifies new anticancer tetrahydrofuran

Nov. 8, 2000

Novel immunomodulators claimed by Abbott in patent literature

Nov. 8, 2000

Selective factor Xa inhibitors designed by Cor Therapeutics researchers

Nov. 8, 2000

Merck issued patent covering new anticoagulants

Nov. 8, 2000

Recent patent covers Bayer's newest agents for HBV

Nov. 7, 2000

Recent AHP patent describes calcitonin inducers particularly useful for osteoporosis

Nov. 7, 2000

Temple researchers identify biologically active anticancer (Z)-styryl benzylsulfones

Nov. 7, 2000

New Gruenenthal compounds bind with high affinity to sodium and calcium channels

Nov. 7, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...